These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema. Shimura M; Yasuda K; Nakazawa T; Hirano Y; Sakamoto T; Ogura Y; Shiono T Retina; 2011 Apr; 31(4):748-54. PubMed ID: 21836404 [TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Williamson TH; O'Donnell A Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292 [TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479 [TBL] [Abstract][Full Text] [Related]
28. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Avitabile T; Longo A; Reibaldi A Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521 [TBL] [Abstract][Full Text] [Related]
29. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema. Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165 [TBL] [Abstract][Full Text] [Related]
30. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Sørensen TL; Haamann P; Villumsen J; Larsen M Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560 [TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema. Gibran SK; Khan K; Jungkim S; Cleary PE Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Chen SD; Sundaram V; Lochhead J; Patel CK Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226 [TBL] [Abstract][Full Text] [Related]
33. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Brasil OF; Smith SD; Galor A; Lowder CY; Sears JE; Kaiser PK Br J Ophthalmol; 2007 Jun; 91(6):761-5. PubMed ID: 17108013 [TBL] [Abstract][Full Text] [Related]
34. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Hirano Y; Sakurai E; Yoshida M; Ogura Y Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000 [TBL] [Abstract][Full Text] [Related]